SMAD3 rs17293632: Understanding Your Genetic Association
The rs17293632 variant is a common genetic change located within the SMAD3 gene. Research has linked this variant to an increased risk of bronchial asthma, with some studies suggesting this effect may be more pronounced in girls.
What each genotype means
Baseline SMAD3 expression
This genotype represents the major allele pair for this variant. Research indicates that individuals with this genotype do not carry the specific allele associated with the observed reduction in SMAD3 gene expression and the associated increased risk of bronchial asthma in girls.
This is the most common genotype across most studied populations.
Increased asthma risk marker
Carrying one copy of the T allele is associated with a statistically significant increase in the risk of bronchial asthma, specifically observed in girls. This variant is linked to decreased SMAD3 gene expression, which may influence TGF-beta signaling and airway remodeling; please discuss any respiratory concerns with your healthcare provider.
This heterozygous genotype is common, appearing in a significant portion of the population depending on ancestral background.
Elevated asthma risk marker
Carrying two copies of the T allele is associated with a higher statistical likelihood of bronchial asthma in girls compared to those without the T allele. Because this variant is linked to altered SMAD3 expression and TGF-beta signaling, you should consult with a clinician regarding any symptoms of asthma or allergic conditions.
This genotype is less common than the C/C or C/T genotypes but is present in many populations.
What is rs17293632?
The rs17293632 variant is a single-nucleotide polymorphism (SNP) located within the SMAD3 gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is found in an intronic region, meaning it sits within a non-coding part of the gene that does not directly provide instructions for making a protein. However, intronic variants can still be highly significant because they often reside in regulatory elements that control how much of a protein is produced, when it is produced, or in which tissues it is active. Because rs17293632 is located in a region that can influence gene expression, researchers study it to understand how it might alter biological pathways related to health and disease.
The Role of the SMAD3 Gene
The SMAD3 gene provides instructions for making a protein that acts as a signal transducer in the TGF-beta (transforming growth factor-beta) signaling pathway. This pathway is a fundamental communication system that cells use to regulate various processes, including cell growth, differentiation, and the body's response to injury. In the context of the lungs, TGF-beta signaling is involved in airway remodeling, a process where the structure of the airways changes in response to chronic inflammation. Because asthma involves both inflammation and structural changes in the bronchial tubes, the SMAD3 protein is a subject of intense interest for scientists studying respiratory health. By modulating how cells respond to TGF-beta, variations in SMAD3 may influence how an individual's airways react to environmental triggers or inflammatory signals.
Research and Asthma Associations
Scientific studies have identified associations between rs17293632 and bronchial asthma, though the strength and nature of these findings vary. For instance, research involving Russian children found that the variant was associated with an increased risk of asthma specifically in girls, while no significant association was observed in boys. Similarly, a study of a Filipino cohort identified an association between this variant and self-reported asthma. Other research has linked SMAD3 variants to various allergic sensitivities and even cardiovascular traits, highlighting the gene's pleiotropic nature—meaning it affects multiple, seemingly unrelated physical traits. It is important to note that these findings are statistical associations observed in specific populations. They do not mean that carrying the variant guarantees the development of asthma, nor does the absence of the variant rule it out. Asthma is a complex condition influenced by a combination of many genetic factors, environmental exposures, and lifestyle elements.
Population Frequency
The rs17293632 variant is considered common across many human populations. Minor allele frequencies (MAF) for this SNP are typically reported around 12% in various studies, indicating that a significant portion of the population carries at least one copy of the variant allele. Because it is a common variant, it is frequently included in large-scale genetic studies and genome-wide association studies (GWAS) aimed at understanding the genetic architecture of common diseases.
Interpreting Your Genetic Information
If you have information about your genotype for rs17293632, it is helpful to view it as one small piece of a much larger biological puzzle. Genetic associations are statistical tools used by researchers to identify pathways involved in disease; they are not diagnostic tests. Having a specific genotype does not provide a medical diagnosis or a prediction of your personal health future. If you have concerns about asthma, allergies, or any other respiratory symptoms, the most important step is to consult with a qualified healthcare professional. They can evaluate your clinical history, physical symptoms, and environmental factors to provide appropriate care. Never use genetic data to make decisions about medications or treatments without first discussing them with your doctor or pharmacist, as they can provide guidance based on your complete health profile.
How common is this variant?
The rs17293632 variant is common, with a minor allele frequency typically reported around 12% across diverse populations.
Frequently asked questions
Does having the rs17293632 variant mean I will get asthma?
No. Genetic associations are statistical findings, not diagnostic predictions. Asthma is a complex condition caused by many genetic and environmental factors working together.
Why is this variant associated with asthma only in girls in some studies?
Biological pathways can interact with sex-specific hormones or developmental factors. Researchers are still investigating why certain genetic risks appear more strongly in one sex than the other.
Can I use this information to change my asthma medication?
No. You should never change your medication or treatment plan based on genetic information. Always consult your doctor or pharmacist regarding any changes to your medical care.
Is SMAD3 involved in other health conditions?
Yes. Because SMAD3 is a key regulator in TGF-beta signaling, it has been studied in relation to cardiovascular health, inflammatory bowel disease, and various allergic responses.
Sources & further reading
Educational information only, last refreshed 10/29/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17293632?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29